The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study of PGG beta glucan in combination with anti-MUC1 antibody (BTH1704) and gemcitabine for the treatment of advanced pancreatic cancer.
 
Neeta K. Venepalli
No Relationships to Disclose
 
Chintan Chandrakant Gandhi
No Relationships to Disclose
 
Howard Ozer
Honoraria - Amgen; Teva
Consulting or Advisory Role - Amgen; Teva
Travel, Accommodations, Expenses - Gilead Sciences
 
Dominic Ho
No Relationships to Disclose
 
Yang Lu
No Relationships to Disclose
 
Hui Xie
No Relationships to Disclose
 
Stephanie A. Berg
No Relationships to Disclose
 
Rozina A. Chowdhery
No Relationships to Disclose
 
Michele Anne Gargano
Employment - Biothera
Stock and Other Ownership Interests - Biothera
 
Ada H. Braun
Employment - Amgen; Biothera
Stock and Other Ownership Interests - Amgen; Biothera
 
Arkadiusz Z. Dudek
Stock and Other Ownership Interests - Biothera
Consulting or Advisory Role - Biothera